Article Text
PDFTherapeutics
Randomised controlled trial
Two weeks of rifaximin relieves global symptoms and bloating in people with IBS without constipation
Statistics from Altmetric.com
Footnotes
-
Competing interests BS has received grants from Takeda, Prometheus, Movetis. Advisor for Salix, Prometheus, Ironwood, Movetis, AstraZeneca.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions